XML 61 R30.htm IDEA: XBRL DOCUMENT v2.4.0.8
Fair Value Measurements And Financial Instruments (Tables)
9 Months Ended
Sep. 28, 2013
Fair Value Disclosures [Abstract]  
Summary Of Components Of Available-For-Sale Securities
The following table summarizes the components of the balance of the Company’s available-for-sale securities at September 28, 2013 and December 29, 2012 (in millions):
 
September 28, 2013
 
December 29, 2012
Adjusted cost
$
7

 
$
9

Gross unrealized gains
26

 
32

Fair value
$
33

 
$
41

Summary Of Financial Assets Measured At Fair Value On A Recurring Basis
A summary of financial assets measured at fair value on a recurring basis at September 28, 2013 and December 29, 2012 is as follows (in millions):
 
Balance Sheet
Classification
September 28, 2013
 
Quoted Prices
In Active
Markets
(Level 1)
 
Significant
Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
Assets
 
 

 
 

 
 

 
 

Money-market securities
Cash and cash equivalents
$
848

 
$
848

 
$

 
$

Available-for-sale securities
Other current assets
33

 
33

 

 

Trading securities
Other assets
254

 
254

 

 

Total assets
 
$
1,135

 
$
1,135

 
$

 
$

 
 
 
 
 
 
 
 
 
Liabilities
 
 
 
 
 
 
 
 
Contingent consideration
Other liabilities
$
136

 
$

 
$

 
$
136

Total liabilities
 
$
136

 
$

 
$

 
$
136


 
Balance Sheet
Classification
December 29, 2012
 
Quoted Prices
In Active
Markets
(Level 1)
 
Significant
Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
Assets
 
 

 
 

 
 

 
 

Money-market securities
Cash and cash equivalents
$
964

 
$
964

 
$

 
$

Available-for-sale securities
Other current assets
41

 
41

 

 

Trading securities
Other assets
231

 
231

 

 

Total assets
 
$
1,236

 
$
1,236

 
$

 
$

Fair Value Inputs, Liabilities, Quantitative Information [Table Text Block]
The recurring Level 3 fair value measurements of our contingent consideration liability include the following significant unobservable inputs (in millions):
Contingent Consideration Liability
Fair Value as of September 28, 2013
Valuation Technique
 
Unobservable Input
 
Range
 
 
 
 
 
 
 
 
 
Endosense regulatory-based milestone
$
136

Probability Weighted Discounted Cash Flow
 
Discount Rate
 
1.15%
-
1.71%
 
 
 
 
Probability of Payment
 
 
 
90%
 
 
 
 
Projected Year of Payment
 
 
 
2014
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]
Additionally, the following table provides a reconciliation of the beginning and ending balances of the Company's contingent consideration liability associated with its Endosense acquisition subsequent to August 19, 2013 as of September 28, 2013 (in millions):

 
Fiscal Year 2013
Beginning balance
$

Purchase price contingent consideration
132

Change in fair value of contingent consideration
1

Foreign currency translation
3

Ending balance
$
136